MomMA Program for Expectant Moms with ADHD
This study is testing a behavioral program called MomMA (Moms Managing ADHD) for pregnant individuals who have Attention-Deficit/Hyperactivity Disorder (ADHD). The MomMA program is a type of behavioral therapy (CBT-based behavioral intervention) that helps expectant parents manage ADHD symptoms during pregnancy and after birth. You might be able to join if you are 18 or older, live in Pennsylvania, speak English, and are between 14 and 22 weeks pregnant with a diagnosis of ADHD. The study aims to see if the MomMA program is acceptable, feasible, and appropriate, and to compare it to usual care (Treatment as Usual or TAU). The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study with a planned enrollment of 80 participants. It will compare the MomMA Intervention to Treatment as Usual (TAU) in pregnant women with ADHD.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Intervention acceptability, feasibility, and appropriateness are measured at Post Intervention (36 weeks gestational age).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Heather M Joseph, DO Assistant Professor of Psychiatry and Pediatrics · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
- Andrea Chronis-Tuscano, PhD Joel & Kim Feller Endowed Professor · PRINCIPAL_INVESTIGATOR · University of Maryland
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Intervention AcceptabilityPost Intervention (36 weeks gestational age)
Therapist and participant report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from rated from 1 (completely disagree) to 5 (completely agree).
- Intervention FeasibilityPost Intervention (36 weeks gestational age)
Therapist and participant report of intervention feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM), rated from 1 (completely disagree) to 5 (completely agree).
- Intervention AppropriatenessPost Intervention (36 weeks gestational age)
Therapist and participant report of intervention appropriateness will be assessed using the 4-item Intervention Appropriateness Measure (IAM), rated from 1 (completely disagree) to 5 (completely agree).
- ADHD Symptom SeverityPost Intervention (36 weeks gestational age) and Postpartum follow-up (4-5 months postpartum)
Number and severity of ADHD symptoms will be self-reported using the Barkley Adult ADHD Rating Scale-IV (BAARS-IV). Number and severity of ADHD symptoms will be self-reported using the Barkley Adult ADHD Rating Scale-IV (BARRS-IV). Total score (range 18-72) and number of symptoms (0-18) will be determined by summing the Inattention (total score: range 9-36; number of symptoms: range 0-9), Hyperactivity (total score: range 5-20; number of symptoms: range 0-5), and Impulsivity (total score: range 4-16; number of symptoms: range 0-4) subscales. On all scales, higher scores indicate greater ADHD symptoms.
- ADHD Functional ImpairmentPost Intervention (36 weeks gestational age) and Postpartum follow-up (4-5 months postpartum)
Impairment in family functioning and self-concept will be assessed on two subscales of the Weiss Functional Impairment Rating Scale (WFIRS-S). Impairment in family functioning and self-concept will be assessed on two subscales of the Weiss Functional Impairment Rating Scale (WFIRS-S). For each scale, mean impairment (range 0-3) and a total impairment score (Family subscale: range 0-24; Self-Concept subscale: range 0-15) will be calculated. Any subscale with at least 2 items scored a 2 or 3, one item scored 3, or a mean score of \>1.5 is considered impaired.
- Perinatal Mood/DistressPost Intervention (36 weeks gestational age) and Postpartum follow-up (4-5 months postpartum)
Symptoms of depression, anxiety, and distress will be assessed using self-report on the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder scale (GAD-7), and Perceived Stress Scale (PSS). Symptoms of depression, anxiety, and distress will be assessed using self-report on the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder scale (GAD-7), and Perceived Stress Scale (PSS). The PHQ-9 (total score range 0-27) measures depression, with higher scores indicating greater depressive symptoms. The GAD-7 (total score range 0-21) measures anxiety, with higher scores indicating greater anxiety symptoms. The PSS (total score range 0-40) measures perceived stress, with higher scores indicating greater perceived stress.